NSUN2 and COVID-19: We further collected BALF from patients with severe and mild COVID-19 with the SARS-CoV-2 Omicron subvariant BA.5.2 and found that NSUN2 expression levels and m5C levels decreased in patients with severe compared to mild COVID-19 (Fig. 7, E and F).